Biopharmaceutical Processing Equipment and Consumables Market Worth $70.84 Billion by 2029
Biopharmaceutical Processing Equipment and Consumables Market Worth $70.84 Billion by 2029
Meticulous Research®– leading global market research company published a research report titled “Biopharmaceutical Processing Equipment and Consumables Market by Product Type {Filtration, Chromatography [Consumables, Equipment], Disposable Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D), and End User- Forecast to 2029.”
According to this latest publication from Meticulous Research, the global biopharmaceutical processing equipment and consumables market is expected to grow at a CAGR of 10.3% to reach $70.84 billion by 2029. Initiatives supporting the adoption of biopharmaceuticals, capacity expansions of biopharmaceutical manufacturing plants, and growing use of single-use technologies in commercial bioproduction are the factors driving the market growth.
Biopharmaceutical Processing Equipment and Consumables Market: Future Outlook
The global biopharmaceutical processing equipment and consumables market study presents, historical market data in terms of values (2020 and 2021), estimated current data (2022), and forecasts it for 2029 –by Product Type (Filtration Systems, Chromatography Equipment and Consumables {Consumables & Equipment}, Bioreactors {Reusable Bioreactors, Disposable/Single-use Bioreactors}, Cell Culture Products {Cell Culture Media [Cell Culture Media, by Physical Form–Dry Powder Media, Liquid Media], [Cell Culture Media, by Type–Off-the-Shelf Media, Custom Media], [Cell Culture Media, by Source-Chemically Defined Media, Natural Media], Reagents and Supplements, Cell and Cell Lines, Serum}, Mixing Systems, Bioprocessing Containers, Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, Other Consumables and Accessories, Services), Application (Commercial Bioproduction {Vaccine Manufacturing, mAb Production, Recombinant Protein Production, Cell and Gene Therapy Production}, Research Bioproduction), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), & Academia and Research Institutes), and GeographyThe study also evaluates industry competitors and analyzes their market share at global and regional levels.
Based on product type, the filtration systems segment is estimated to account for the largest share of the market in 2022. The technological developments in filtration technologies and accelerated developments of single-use filtration systems to meet the growing need for single-use bioprocessing systems are contributing to the largest market share.
Based on application, the market is segmented into commercial bioproduction and research bioproduction. The commercial bioproduction segment is estimated to account for the largest share of the market in 2022, owing to the growing number of biopharmaceuticals in the clinical development and nearing patent expiry of biologics.
Based on end user, the pharmaceutical and biopharmaceutical companies segment is estimated to account for the largest share of the market in 2022. The largest revenue share is attributed to the growing demand for biopharmaceutical equipment for commercial bioproduction in pharmaceutical and biopharmaceutical companies.
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Ireland, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America, and Middle East & Africa.
Europe is estimated to command the largest share of the biopharmaceutical processing equipment and consumables market in 2022, followed by North America and Asia-Pacific. Germany is estimated to be the largest shareholding market in Europe in 2022. The growth of this market is primarily driven by the increase in pharmaceutical export, government grants, and funding to biotech and biopharmaceutical companies, and biopharmaceutical companies expanding their capacities for biologics-based drugs and therapeutics to meet the increasing demand of the market.
Download Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=4200?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=23-03-2023
The key players operating in the global biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).
Biopharmaceutical Processing Equipment and Consumables Market, by Product Type
Chromatography Equipment and Consumables
Disposable/Single-use Bioreactors
Cell Culture Media, by Physical Form
Cell Culture Media, by Type
Cell Culture Media, by Source
Other Equipment and Consumables
Service
(Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors)
Biopharmaceutical Processing Equipment and Consumables Market, by Application
Recombinant Protein Production
Cell and Gene Therapy Production
Biopharmaceutical Processing Equipment and Consumables Market, by End User
Pharmaceutical and Biopharmaceutical Companies
Contract Development and Manufacturing Organizations (CDMOs)
Academia and Research Institutes
Biopharmaceutical Processing Equipment and Consumables Market, by Geography
Download Sample report:https://www.meticulousresearch.com/download-sample-report/cp_id=4200?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=23-03-2023
